About Aurorium
Aurorium is a company based in Geleen (Netherlands) founded in 2006 by Uwe Wascher was acquired by Vertellus in February 2022. It operates as a Professional Services and Direct-to-Consumer (D2C). Aurorium offers products and services including Haelium™ Pharmaceutical Solutions, NaOH Solutions, Castorlatum™ Emollient, Xibond™ Additives, and Bersize™ ASA Technology.
- Headquarter Geleen, Netherlands
- Founders Uwe Wascher
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurorium
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurorium
Aurorium offers a comprehensive portfolio of products and services, including Haelium™ Pharmaceutical Solutions, NaOH Solutions, Castorlatum™ Emollient, Xibond™ Additives, and Bersize™ ASA Technology.
Solutions are developed to enhance drug efficacy significantly.
Vertically integrated manufacturing is provided in North America.
Plant-based alternative to petroleum jelly is offered here.
Dimensional stability in mobility environments is ensured effectively.
Efficiency in paper sizing is driven by technology.
Funding Insights of Aurorium
Investors in Aurorium
Aurorium has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Vertellus and Brightlands Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brightlands Venture Partners is focused on venture capital investments.
|
Locked | Locked | Locked | |
|
Specialty chemicals are supplied for pharmaceuticals and diverse industries.
|
Locked | Locked | Locked |
Investor details for Aurorium
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurorium
Investment portfolio details for Aurorium
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurorium
Detailed financials for Aurorium
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurorium Comparisons
Peer comparison for Aurorium
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurorium
Detailed competitors of Aurorium
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurorium
Complete news archive for Aurorium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurorium
Aurorium was founded in 2006.
Aurorium is headquartered in Geleen, Netherlands. It is registered at Geleen, Limburg, Netherlands.
Patrick Muezers is the current CEO of Aurorium.
Aurorium is engaged in providing specialty ingredients and performance-enhancing materials across various industries. Sectors such as healthcare, personal care, infrastructure, mobility, and paper packaging are served. Solutions like Haelium for pharmaceuticals, NaOH solutions, and Castorlatum emollients are developed. Sustainable and nature-derived alternatives are engineered for performance. Market-leading technical expertise and exceptional partnership experiences are emphasized to create life-enhancing products globally.
Aurorium offers Haelium™ Pharmaceutical Solutions, NaOH Solutions, Castorlatum™ Emollient, Xibond™ Additives, and Bersize™ ASA Technology.
Aurorium has 2 investors. Key investors include Vertellus, and Brightlands Venture Partners.